期刊
INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 631, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ijpharm.2022.122501
关键词
Polysarcosine; Poly(?-benzyl glutamate); NCA polymerization; Self-assembly; Nanoparticles; Paclitaxel
New stealth amphiphilic copolymers based on polysarcosine (PSar) have been studied for their potential use as excipients in nanomedicine. The copolymers were synthesized by ring opening polymerization of N-carboxyanhydrides (NCAs) and characterized by FTIR, 1H NMR, and SEC. Nanoparticles loaded with paclitaxel were obtained and showed improved water solubility.
New stealth amphiphilic copolymers based on polysarcosine (PSar) rather than poly(ethylene glycol) (PEG) have gained more attention for their use as excipients in nanomedicine. In this study, several polysarcosine-b-poly (gamma-benzyl glutamate) (PSar-b-PGluOBn) block copolymers were synthesized by ring opening polymerization (ROP) of the respective N-carboxyanhydrides (NCAs) and were characterized by Fourier-transform infrared spectroscopy (FTIR), proton nuclear magnetic resonance (1H NMR) and size-exclusion chromatography (SEC). Copolymers had different PGluOBn block configuration (racemic L/D, pure L or pure D), degrees of polymeri-zation of PSar between 28 and 76 and PGluOBn between 9 and 93, molar masses (Mn) between 5.0 and 24.6 kg. mol-1 and dispersities (D) lower than 1.4. Nanoparticles of PSar-b-PGluOBn loaded with paclitaxel (PTX), a hydrophobic anti-cancer drug, were obtained by nanoprecipitation. Their hydrodynamic diameter (Dh) ranged from 27 to 118 nm with polydispersity indexes (PDI) between 0.01 and 0.20, as determined by dynamic light scattering (DLS). Their morphology was more spherical for copolymers with a racemic L/D PGluOBn block configuration synthesized at 5 degrees C. PTX loading efficiency was between 63 and 92 % and loading contents be-tween 7 and 15 %. Using PSar-b-PGluOBn copolymers as excipients, PTX apparent water-solubility was signif-icantly improved by a factor up to 6600 to 660 mu g.mL-1.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据